Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to SayZacks Investment Research • 05/07/26
Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations WebsitePRNewsWire • 05/07/26
New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure ProceduresPRNewsWire • 04/24/26
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026PRNewsWire • 04/01/26
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure SystemPRNewsWire • 03/30/26
What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past YearThe Motley Fool • 03/20/26
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS TechnologyPRNewsWire • 02/23/26
Haemonetics to Present at Raymond James 47th Annual Institutional Investors ConferencePRNewsWire • 02/20/26
Haemonetics (HAE) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research • 02/05/26